专利检索 ap:("CHANGZHOU PHARMACEUTICAL FACTO" OR "MA XIAOPENG" OR "WANG BING" OR "XI SHAOQI") AND inv:"XI SHAOQI" 第 1 页

1.

发明公开
EXENDIN 4 POLYPEPTIDE FRAGMENTS AND USE THEREOF 审中-公开
标题翻译：艾塞那肽-4多肽片段和它们的用途

公开(公告)号：EP1908778A4

公开(公告)日：2009-08-12

申请号：EP06753060

申请日：2006-06-29

申请人： CHANGZHOU PHARMACEUTICAL FACTO , MA XIAOPENG , WANG BING , XI SHAOQI

发明人： MA XIAOPENG , WANG BING , XI SHAOQI

IPC分类号： C07K14/575

CPC分类号： C07K14/57563 , A61K38/00

摘要： Exendin 4 polypeptide fragments having blood sugar lowering action which can be used for treating type II diabetes are provided. The polypeptide fragments have the sequence of HGEGTX1TSDLSKQX2EEEAVX3LFIEWLKNGX4PX5, wherein X1 represents Phe or Tyr, X2 represents Met, Ile or Leu, X3 represents Lys, X4 represents Gly or deletion, and X5 represents Arg or deletion. The process for preparing the Exendin 4 polypeptide fragments is also provided.